IMVT Immunovant, Inc.
Price Chart
Executive Summary
Director Andrew J. Fromkin filed a Form 144 on May 28, 2026, indicating intent to sell up to 221,951 shares of Immunovant common stock (approx. $7.4M at recent prices, ~0.11% of market cap). The shares were acquired primarily via stock option exercises and open-market purchases from 2021-2026, and are being sold through a broker at current market prices. The filing is routine for a director monetizing exercised options and does not suggest material company-specific concerns.
Actionable Insight
Monitor for the execution of this sale (Form 4 filing) over the coming weeks. The dollar amount is modest relative to market cap and liquidity — unlikely to meaningfully pressure the stock. The director is simply monetizing option exercises in a routine manner. No earnings or catalyst event is imminent based on this filing.
Key Facts
- Form 144 filed May 28, 2026 by director Andrew J. Fromkin
- Proposed sale of 221,951 shares of common stock
- Estimated aggregate value ~$7.44M based on ~$33.50 implied price (derived from stated $7.44M / 221,951 shares)
- Shares acquired via multiple option exercises and RSU vesting events between 2021 and 2026
- Sale not yet executed — Form 144 is an advance notice of intent to sell
- Market cap ~$6.7B; proposed sale represents ~0.0033% of shares outstanding
- Recent insider activity shows 3 prior sells totaling $574K in the last 30 days
Financial Impact
$7.44 million in potential selling proceeds, a minor fraction of $6.7B market cap
Risk Factors
- Insider selling could be interpreted negatively by the market, though the amount is very small relative to total shares outstanding
- The proposed sale has not been executed; market conditions or blackout periods could prevent it
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005198 |
| Document: 0001950047-26-005198-index.html | 0001950047-26-005198 |
| Document: 0001950047-26-005198.txt | 0001950047-26-005198 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 28, 2026
17d ago
|
144
| $33.30 $31.11 | ▼ −6.58% | ▼ −4.08% | $33.62 (+0.96%) |
|
May 20, 2026
25d ago
|
8-K
| $35.56 $33.41 | ▼ −6.05% | ▼ −7.28% | $33.62 (−5.46%) |
|
May 20, 2026
25d ago
|
Press Release
| $35.56 $33.41 | ▼ −6.05% | ▼ −7.28% | $33.62 (−5.46%) |
|
Apr 23, 2026
7w ago
|
Insider Cluster
| $28.91 $26.95 | ▼ −6.78% | ▼ −8.26% | $33.62 (+16.29%) |
|
Apr 2, 2026
10w ago
|
Insider Cluster
| $24.50 $24.50 | · 0.00% | ▼ −3.62% | $33.62 (+37.22%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access